feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Alzecure: Receives Approval to Start ACD856 Phase I “MAD” Study
We give a brief comment on today's news that Alzecure has recieved approval to start the "MAD"-part of its phase 1 study for ACD856.
FT
Fredrik Thor
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans